Trade AbbVie ABBV

Sell
 Buy

AbbVie live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

AbbVie News

Ava Grace 2025 Nov 08, 00:00

AI Funding Concerns Trigger Tech Stock Sell-Off

Sophia Claire 2025 Nov 08, 00:00

Gold Price Outlook: Currency Devaluation Trade Still Alive

Liam James 2025 Nov 08, 00:00

JPMorgan Sees Buying Opportunity Amid Market Jitters

Emma Rose 2025 Nov 07, 00:00

The Fed's Balance Sheet Expansion: Drivers and Potential Implications

Noah Lee 2025 Nov 07, 00:00

LME Aluminum Bull Run: Is a Structural Deficit Emerging?

Frances Wang 2025 Nov 06, 16:00

Gold and silver prices are up: what's happening to Gold (XAU/USD) and XAG?

Frances Wang 2025 Nov 06, 16:00

Nvidia Competitors Analysis (2026), NVDA Stock: AMD, Intel, Qualcomm, AVGO

Frances Wang 2025 Nov 05, 16:00

Crypto market update: Ethereum price drops, Bitcoin price falls below $104K

Frances Wang 2025 Nov 05, 16:00

XRP price prediction: XRP rebounds, Is XRP expected to go high?

Frances Wang 2025 Nov 05, 16:00

Tesla stock jumps 4% today: what’s driving the TSLA share price?

Latest news

Show more
Emma Rose 2025 Nov 08, 23:10

Bitcoin Power Law Suggests Potential Surge to $142,000 Amidst Analyst Revisions

Ava Grace 2025 Nov 08, 21:10

Ex-Binance CEO CZ Expresses Surprise at Trump Pardon, Denies Business Ties

Sophia Claire 2025 Nov 08, 19:00

The Eroding Nation-State: How Blockchain Challenges Traditional Governance

Sophia Claire 2025 Nov 08, 13:10

Pakistan Considers Rupee-Backed Stablecoin Amid Crypto Regulation Delays

Liam James 2025 Nov 08, 12:00

Arthur Hayes Reveals Significant Zcash Investment: Now Second Largest Holding in Maelstrom Fund After Bitcoin

Emma Rose 2025 Nov 08, 09:20

Crypto Markets Update: Key Highlights for November 8, 2025

Noah Lee 2025 Nov 08, 07:30

ARK Invest Increases BitMine Exposure, Trims Tesla Holdings

Liam James 2025 Nov 08, 06:50

Mistrial Declared in Ethereum MEV Exploit Case: Brothers Accused of Fraud & Money Laundering

Info

Spread

1.45

Spread (%)

0.6645 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

387340009472

Shares Outstanding

1767384632

Earnings Date (Next)

0000-00-00

Div Yield

2026-02-17

Ex-Dividend Date

2026-01-16

Forward annual dividend rate

6.92

Forward annual dividend yield

0.0316

EPS

1.31

Learn more about this instrument

AbbVie AbbVie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Nov 06, 16:00

How to start cryptocurrency trading: how to trade BTC Price (BTC/USD) CFDs?

Ghko B 2025 Nov 06, 16:00

Xom Stock Forecast: What is the future forecast for XOM?

Ghko B 2025 Nov 06, 16:00

Top Australian Shares: Argo Investments, BHP, CBA stock and more

Trustpilot